Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Top FDA vaccine scientist resigns, denouncing Kennedy’s “misinformation and lies”
Dr. Peter Marks makes clear that a central impetus behind his resignation was Kennedy’s criminal response to the deepening ...
Let’s Have a Little Chat About the HPV Vaccine
Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually ...
MRK Investors Have Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...
Law19d
Judge: 'Evidence Is Lacking' to Impose Warning on HPV Vaccine Gardasil
More than 200 lawsuits demand warnings on Gardasil labels about an autoimmune disease called Postural Orthostatic Tachycardia Syndrome, or POTS, and Primary Ovarian Insufficiency, or POI ...
Is Merck Stock a Bargain Buy?
Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...
It took me 10 years to get the HPV vaccine. Let's talk about the facts. | Opinion
My medical degree and conversations with doctors helped me understand why it makes sense for adolescents to be vaccinated, ...
Merck prevails in Gardasil safety litigation
A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a vaccine to prevent cervical and other fatal cancers. The decision made public on ...
Which Dow Jones Stock Is Cheaper, Amgen or Merck?
Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...
Merck & Co.: Looming Patent Expiries For Key Drugs Weaken Longer-Term Outlook
Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.